BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32014143)

  • 41. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
    Fabbri A; Gozzetti A; Rigacci L
    Cancer; 2011 Aug; 117(15):3530; author reply 3531. PubMed ID: 21287541
    [No Abstract]   [Full Text] [Related]  

  • 42. Pembrolizumab and lenalidomide induced remission in refractory double-hit lymphoma.
    Chan TS; Khong PL; Kwong YL
    Ann Hematol; 2016 Oct; 95(11):1917-8. PubMed ID: 27473194
    [No Abstract]   [Full Text] [Related]  

  • 43. Identification of a Patient Cohort with Relapsing Diffuse Large B-Cell Lymphoma with a Low International Prognostic Index in PET/CT Using a 2-Gene (LMO2/TNFRSF9) Scoring System.
    Omidvar N; Tekin N; Conget P; Bruna F; Timar B; Gagyi E; Basak R; Auewarakul C; Sritana N; Cerci JJ; Dimamay MP; Gyorke T; Redondo F; Nair R; Gorospe C; Paez D; Fanti S; Ozdag H; Padua RA; Carr R
    Acta Haematol; 2020; 143(6):600-602. PubMed ID: 32187599
    [No Abstract]   [Full Text] [Related]  

  • 44. Outcomes of very elderly patients with aggressive B-cell non-Hodgkin lymphoma treated with reduced-dose chemotherapy.
    Iioka F; Izumi K; Kamoda Y; Akasaka T; Ohno H
    Int J Clin Oncol; 2016 Jun; 21(3):498-505. PubMed ID: 26463529
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial.
    Hüttmann A; Rekowski J; Müller SP; Hertenstein B; Franzius C; Mesters R; Weckesser M; Kroschinsky F; Kotzerke J; Ganser A; Bengel FM; La Rosée P; Freesmeyer M; Höffkes HG; Hertel A; Behringer D; Prange-Krex G; Griesshammer M; Holzinger J; Wilop S; Krohn T; Raghavachar A; Maschmeyer G; Brink I; Schroers R; Gaska T; Bernhard H; Giagounidis A; Schütte J; Dienst A; Hautzel H; Naumann R; Klein A; Hahn D; Pöpperl G; Grube M; Marienhagen J; Schwarzer A; Kurch L; Höhler T; Steiniger H; Nückel H; Südhoff T; Römer W; Brinkmann M; Ose C; Alashkar F; Schmitz C; Dürig J; Hoelzer D; Jöckel KH; Klapper W; Dührsen U
    Ann Hematol; 2019 Apr; 98(4):897-907. PubMed ID: 30610279
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.
    Zinzani PL; Stefoni V; Finolezzi E; Brusamolino E; Cabras MG; Chiappella A; Salvi F; Rossi A; Broccoli A; Martelli M
    Clin Lymphoma Myeloma; 2009 Oct; 9(5):381-5. PubMed ID: 19858058
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic factors of primary gastric diffuse large B cell lymphoma: a retrospective study of 75 cases in China.
    Wu YX; Liu B; Chen L; Li JH; Chen SQ
    Ann Hematol; 2013 Jun; 92(6):861-2. PubMed ID: 23238898
    [No Abstract]   [Full Text] [Related]  

  • 48. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
    Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A
    Cancer; 2011 Mar; 117(5):964-73. PubMed ID: 20960528
    [TBL] [Abstract][Full Text] [Related]  

  • 49. "Do Not Ignore Musculoskeletal Pain"-Initial Presentation of a Rare Malignant Disease: Case Report and Literature Review.
    Patel I; Akoluk A; Upadhyaya V; Makadia S; Douedi S; Farooq T; Flynn D; Levitt M; Hossain MA
    J Investig Med High Impact Case Rep; 2020; 8():2324709620941316. PubMed ID: 32660277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A rare case of primary high-grade large B-cell lymphoma of the sciatic nerve.
    Advani P; Paulus A; Murray P; Jiang L; Goff R; Pooley R; Jain M; Garner H; Foran J
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):e117-20. PubMed ID: 25617034
    [No Abstract]   [Full Text] [Related]  

  • 51. Rituximab plus CHOP for diffuse large-B-cell lymphoma.
    Akhtar S; Maghfoor I
    N Engl J Med; 2002 Jun; 346(23):1830-1; author reply 1830-1. PubMed ID: 12050349
    [No Abstract]   [Full Text] [Related]  

  • 52. [Thyroid scintigraphy and body scanning with 67 Ga in a case of primary thyroid lymphoma].
    Hervás Benito I; Vera Espallardo F; Saura Quiles A; González Cabezas P; Bello Arques P; Rivas Sánchez A; Alonso Monfort J; Pérez Velasco R; Mateo Navarro A
    Rev Esp Med Nucl; 2001 Oct; 20(6):462-5. PubMed ID: 11578581
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Favorable outcome of primary mediastinal large B-cell lymphoma patients treated with sequential RCHOP-RICE regimen without radiotherapy.
    Goldschmidt N; Kleinstern G; Orevi M; Paltiel O; Ben-Yehuda D; Gural A; Libster D; Lavie D; Gatt ME
    Cancer Chemother Pharmacol; 2016 May; 77(5):1053-60. PubMed ID: 27056383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
    Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
    Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Magnetic resonance imaging of primary cardiac lymphoma.
    Khuddus MA; Schmalfuss CM; Aranda JM; Pauly DF
    Clin Cardiol; 2007 Mar; 30(3):144-5. PubMed ID: 17385706
    [No Abstract]   [Full Text] [Related]  

  • 56. [Rectal diffuse large B cell lymphoma appearing after immunosuppression for ulcerative colitis. Report of one case].
    Quera R; Flores L; Simian D; Kronberg U; Vial MT; de Guevara DL; García-Rodríguez MJ
    Rev Med Chil; 2017 Oct; 145(10):1342-1348. PubMed ID: 29488576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of radiation therapy in a patient with primary pancreatic lymphoma.
    Shahar KH; Carpenter LS; Jorgensen J; Truong L; Baker K; Teh BS
    Clin Lymphoma Myeloma; 2005 Sep; 6(2):143-5. PubMed ID: 16231854
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Difficult Diagnosis between B Cell Lymphoma and Classical Hodgkin's Lymphoma.
    Rentas Torres Y; Rodríguez-López JL; Valentin M; Silva H
    Bol Asoc Med P R; 2015; 107(3):98-101. PubMed ID: 26742206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial.
    Pardal E; Coronado M; Martín A; Grande C; Marín-Niebla A; Panizo C; Bello JL; Conde E; Hernández MT; Arranz R; Bargay J; González-Barca E; Pérez-Ceballos E; Montes-Moreno S; Caballero MD
    Br J Haematol; 2014 Nov; 167(3):327-36. PubMed ID: 25066542
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Primary cardiac lymphoma detected by myocardial perfusion imaging: case report.
    Trost B; Croft L; Nair A; Henzlova M
    J Nucl Cardiol; 2007 Jan; 14(1):e6-10. PubMed ID: 17276296
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.